News //

Looking to Advance New Drugs to the Clinic, UChicago Spinout Pyxis Files for $100M IPO

The University of Chicago spinout Pyxis Oncology has filed for an initial public offering (IPO) after earlier this year signing a worldwide licensing agreement with Pfizer and raising $152 million…
News //

UChicago Spinout Pyxis Secures $152 Million Series B, Signs Licensing Agreement with Pfizer

The University of Chicago spinout Pyxis Oncology has signed a worldwide licensing agreement with Pfizer after raising $152 million to further advance its portfolio of potent biologics. Pyxis in 2019…
News //

UChicago Invests $300,000 in Groundbreaking New Immunotherapy Startup Founded by University Professor as Part of $22 Million Series A

Pyxis Oncology is the sixth recipient of a venture investment from the UChicago Startup Investment Program.

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept